-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MiZNagmSKqo/mzXepEAMebM1x1SvPnrIUn34CYKjHSXpyMVl22HPt56+m5Q2goLA vZUfi/lZ7ejSdLxza0B6Ng== 0000950116-99-001570.txt : 19990817 0000950116-99-001570.hdr.sgml : 19990817 ACCESSION NUMBER: 0000950116-99-001570 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990630 FILED AS OF DATE: 19990816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENESIS HEALTH VENTURES INC /PA CENTRAL INDEX KEY: 0000874265 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 061132947 STATE OF INCORPORATION: PA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: SEC FILE NUMBER: 001-11666 FILM NUMBER: 99690798 BUSINESS ADDRESS: STREET 1: 101 EAST STATE STREET CITY: KENNETT SQUARE STATE: PA ZIP: 19348 BUSINESS PHONE: 6104446350 MAIL ADDRESS: STREET 1: 101 EAST STATE STREET CITY: KENNETT SQUARE STATE: PA ZIP: 19348 NT 10-Q 1 FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 --------------------- NOTIFICATION OF LATE FILING SEC FILE NUMBER 1-11666 --------------------- --------------------- CUSIP NUMBER --------------------- (Check One): [ ] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q and Form 10-QSB [ ] Form N-SAR For Period Ended: June 30, 1999 ------------------------------------------------------ [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: --------------------------------------- - -------------------------------------------------------------------------------- Read Attached Instruction Sheet Before Preparing Form. Please Print or Type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. - -------------------------------------------------------------------------------- If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: ------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- Part I--Registrant Information - -------------------------------------------------------------------------------- Full Name of Registrant: GENESIS HEALTH VENTURES, INC. ----------------------------------------------- Former Name if Applicable: N/A --------------------------------------------- Address of Principal Executive Office (Street and Number) 101 EAST STATE STREET ----------------------------------------------------------------------- City, State and Zip Code: KENNETT SQUARE, PA 19348-3021 ----------------------------------------------------------------------- - -------------------------------------------------------------------------------- Part II--Rules 12b-25 (b) and (c) - -------------------------------------------------------------------------------- If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b) [ss. 23,047], the following should be completed. (Check box if appropriate) [X] (a) The reasons described in reasonable detail in part III of this form could not be eliminated without unreasonable effort or expense; [X] (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and [ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. - -------------------------------------------------------------------------------- Part III--Narrative - -------------------------------------------------------------------------------- State below in reasonable detail the reasons why Form 10-K and Form 10-KSB, 20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion thereof could not be filed within the prescribed period. (Attached Extra Sheets if Needed) THE COMPANY IS IN DISCUSSIONS WITH ITS SENIOR BANK GROUP REGARDING AMENDMENTS TO ITS SENIOR BANK CREDIT FACILITY WHICH, IN PART, WOULD MAKE CERTAIN FINANCIAL COVENANTS AS OF JUNE 30, 1999 AND PROSPECTIVELY LESS RESTRICTIVE. THE COMPANY IS ALSO SEEKING MODIFICATIONS TO ITS SENIOR BANK CREDIT FACILITY AS A RESULT OF THE AGREEMENT IN PRINCIPLE BETWEEN THE COMPANY AND THE CYPRESS GROUP AND TEXAS PACIFIC GROUP, ITS CO-INVESTOR PARTNERS IN GENESIS ELDERCARE CORP., TO SIMPLIFY THE JOINT-VENTURE STRUCTURE. THE FORM 10-Q FOR THE FISCAL QUARTER ENDED JUNE 30, 1999 FOR THE COMPANY COULD NOT BE FILED WITHIN THE PRESCRIBED PERIOD BECAUSE THE COMPANY WAS UNABLE TO COMPLETE CERTAIN INFORMATION KEY TO FILING A TIMELY AND ACCURATE REPORT ON THE FINANCIAL CONDITION OF THE COMPANY. SUCH INABILITY COULD NOT HAVE BEEN ELIMINATED BY THE COMPANY WITHOUT UNREASONABLE EFFORT OR EXPENSE. - -------------------------------------------------------------------------------- Part IV--Other Information - -------------------------------------------------------------------------------- (1) Name and telephone number of person to contact in regard to this notification GEORGE V. HAGER, JR. 610-444-6350 ----------------------------------------------------------------------- (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under section 13 or 115(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). [X] Yes [ ] No (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? [ ] Yes [X] No If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. GENESIS HEALTH VENTURES, INC. ---------------------------------------------------- (Name of Registrant as specified in charter) has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized. Date: August 16, 1999 /s/ George V. Hager, Jr. ---------------------- By: --------------------------------- GEORGE V. HAGER, JR. EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER - -------------------------------------------------------------------------------- INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form. - -------------------------------------------------------------------------------- ATTENTION Intention misstatements or omissions of fact constitute Federal Criminal Violations (see 18 U.S.C. 1001). -----END PRIVACY-ENHANCED MESSAGE-----